or Try an Advanced Search...

    Technical Analysis for OCX - OncoCyte Corporation

    Grade Last Price % Change Price Change
    C 2.95 0.00% 0.00
    OCX closed unchanged on Monday, July 1, 2024, on 10.15 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical OCX trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Volume Surge Other 0.00%
    Calm After Storm Range Contraction 0.00%
    Stochastic Reached Overbought Strength 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Earnings Movers Other 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    MACD Bullish Centerline Cross Bullish 0.00%
    Calm After Storm Range Contraction 0.00%
    Older End-of-Day Signals for OCX ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 5 hours ago
    60 Minute Opening Range Breakdown about 5 hours ago
    Possible NR7 about 6 hours ago
    Possible Pocket Pivot about 8 hours ago
    200 DMA Resistance about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    OCX Chart by TradingView
    Basic chart:

    Profile

    OncoCyte Corporation focuses on developing diagnostic tests for the detection of breast, bladder, and lung cancers. The company was incorporated in 2009 and is based in Alameda, California. OncoCyte Corporation is a subsidiary of BioTime Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Oncology Stem Cell Breast Cancer Cell Biology Diagnostic Tests Lung Cancer

    Is OCX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 24 Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move
    Jun 17 OncoCyte appoints CFO
    Jun 17 Oncocyte Appoints Andrea James as Chief Financial Officer
    Jun 5 OncoCyte's Innovative Approach: Potential in Precision Diagnostics
    Jun 3 Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
    May 30 Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
    May 16 OncoCyte Corporation (OCX) Q1 2024 Earnings Call Transcript
    May 15 OncoCyte GAAP EPS of -$1.13 misses by $0.46, revenue of $0.18M misses by $0.17M
    May 15 Oncocyte Reports First Quarter 2024 Financial Results
    May 14 OncoCyte Q1 2024 Earnings Preview
    See more OCX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.856
    52 Week Low 2.08
    Average Volume 36,901
    200-Day Moving Average 2.98
    50-Day Moving Average 2.73
    20-Day Moving Average 2.75
    10-Day Moving Average 2.78
    Average True Range 0.20
    RSI (14) 59.51
    ADX 11.94
    +DI 19.28
    -DI 10.57
    Chandelier Exit (Long, 3 ATRs) 2.46
    Chandelier Exit (Short, 3 ATRs) 3.15
    Upper Bollinger Bands 2.96
    Lower Bollinger Band 2.54
    Percent B (%b) 0.99
    BandWidth 14.95
    MACD Line 0.03
    MACD Signal Line 0.00
    MACD Histogram 0.0253
    Fundamentals Value
    Market Cap 24.37 Million
    Num Shares 8.26 Million
    EPS -3.37
    Price-to-Earnings (P/E) Ratio -0.88
    Price-to-Sales 16.72
    Price-to-Book 0.63
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.24
    Resistance 3 (R3) 3.24 3.15 3.19
    Resistance 2 (R2) 3.15 3.08 3.15 3.17
    Resistance 1 (R1) 3.05 3.03 3.01 3.05 3.16
    Pivot Point 2.96 2.96 2.94 2.96 2.96
    Support 1 (S1) 2.86 2.89 2.82 2.86 2.74
    Support 2 (S2) 2.77 2.84 2.77 2.73
    Support 3 (S3) 2.67 2.77 2.71
    Support 4 (S4) 2.67